Liposomal amphotericin B followed by voriconazole for secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients

被引：0
|
作者：
Allinson, K.
Kolve, H.
Gumbinger, H. G.
Vormoor, H. J.
Ehlert, K.
Groll, A. H.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0924-8579(07)70816-6
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [21] Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients
    Cordonnier, C
    Maury, S
    Pautas, C
    Bastié, JN
    Chehata, S
    Castaigne, S
    Kuentz, M
    Bretagne, S
    Ribaud, P
    BONE MARROW TRANSPLANTATION, 2004, 33 (09) : 943 - 948
  • [22] Safety & Efficacy of Liposomal Amphotericin B Followed By Micafungin to Prevent Invasive Fungal Infection in Pediatric Allogeneic Stem Cell Transplantation Recipients
    Shah, Tishi
    Elmacken, Mona
    Small, Tania
    Militano, Olga
    Flower, Allyson
    Van De Ven, Carmella
    Awasthi, Aradhana
    Hamby, Carl
    Ayello, Janet
    Fabricatore, Sandra
    Harrison, Lauren
    Morris, Erin
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S185 - S186
  • [23] Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection
    Pepeler, Mehmet Sezgin
    Yildiz, Seyma
    Yegin, Zeynep Arzu
    Ozkurt, Zubeyde Nur
    Tunccan, Ozlem Guzel
    Erbas, Gonca
    Kokturk, Nurdan
    Kalkanci, Ayse
    Yildirim, Zeki
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2018, 12 (09): : 799 - 805
  • [24] Liposomal Amphotericin B prophylaxis of invasive fungal infections in children and adolescents undergoing haematopoietic stem cell transplantation
    Sovinz, P.
    Schwinger, W.
    Lackner, H.
    Benesch, M.
    Strenger, V.
    Schmidt, S.
    Urban, C.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S154 - S154
  • [25] Amphotericin B inhalations as prophylaxis against invasive aspergillus infections in allogeneic stem cell recipients
    Nihtinen, A.
    Anttila, V. -J.
    Volin, L.
    Juvonen, E.
    Ruutu, T.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S270 - S271
  • [26] Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation
    Roman, Elizabeth
    Osunkwo, Ifeyinwa
    Militano, Olga
    Cooney, Erin
    van de Ven, Carmella
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2008, 50 (02) : 325 - 330
  • [27] Safety of a weekly administration of 10 mg/kg of liposomal amphotericin B for antifungal prophylaxis in allogeneic stem cell transplant and acute leukaemia patients
    Cordonnier, C
    Mohty, M
    Faucher, C
    Vey, N
    Pautas, C
    Robin, M
    Mahi, L
    Ribaud, P
    BONE MARROW TRANSPLANTATION, 2006, 37 : S178 - S178
  • [28] High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
    El-Cheikh, J.
    Faucher, C.
    Furst, S.
    Duran, S.
    Berger, P.
    Vey, N.
    Stoppa, A-M
    Bouabdallah, R.
    Gastaut, J-A
    Viens, P.
    Blaise, D.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 (05) : 301 - 306
  • [29] Population pharmacokinetics of liposomal amphotericin B, caspofungin and the combination of both in allogeneic hematopoietic stem cell recipients
    Wuerthwein, G.
    Young, C.
    Lanvers-Kaminsky, C.
    Silling, G.
    Hempel, G.
    Boos, J.
    Groll, A. H.
    MYCOSES, 2011, 54 (05) : 408 - 408
  • [30] Population pharmacokinetics of liposomal amphotericin B, caspofungin and the combination of both in allogeneic hematopoietic stem cell recipients
    Groll, A. H.
    Young, C.
    Lanvers-Kaminsky, C.
    Silling, G.
    Hempel, G.
    Boos, J.
    Wuerthwein, G.
    MYCOSES, 2009, 52 : 110 - 110
12345